Nalivaika EA - Search Results

1

Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.

Prabu-Jeyabalan M, Nalivaika EA, King NM, Schiffer CA. Prabu-Jeyabalan M, et al. Among authors: nalivaika ea. J Virol. 2003 Jan;77(2):1306-15. doi: 10.1128/jvi.77.2.1306-1315.2003. J Virol. 2003. PMID: 12502847 Free PMC article.

2

How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.

Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. Prabu-Jeyabalan M, et al. J Mol Biol. 2000 Sep 1;301(5):1207-20. doi: 10.1006/jmbi.2000.4018. J Mol Biol. 2000. PMID: 10966816

3

Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.

King NM, Melnick L, Prabu-Jeyabalan M, Nalivaika EA, Yang SS, Gao Y, Nie X, Zepp C, Heefner DL, Schiffer CA. King NM, et al. Among authors: nalivaika ea. Protein Sci. 2002 Feb;11(2):418-29. doi: 10.1110/ps.25502. Protein Sci. 2002. PMID: 11790852 Free PMC article.

4

Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.

Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. Prabu-Jeyabalan M, et al. Structure. 2002 Mar;10(3):369-81. doi: 10.1016/s0969-2126(02)00720-7. Structure. 2002. PMID: 12005435 Free article.

5

Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.

King NM, Prabu-Jeyabalan M, Nalivaika EA, Wigerinck P, de Béthune MP, Schiffer CA. King NM, et al. Among authors: nalivaika ea. J Virol. 2004 Nov;78(21):12012-21. doi: 10.1128/JVI.78.21.12012-12021.2004. J Virol. 2004. PMID: 15479840 Free PMC article.

6

Combating susceptibility to drug resistance: lessons from HIV-1 protease.

King NM, Prabu-Jeyabalan M, Nalivaika EA, Schiffer CA. King NM, et al. Among authors: nalivaika ea. Chem Biol. 2004 Oct;11(10):1333-8. doi: 10.1016/j.chembiol.2004.08.010. Chem Biol. 2004. PMID: 15489160

7

Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.

Prabu-Jeyabalan M, Nalivaika EA, King NM, Schiffer CA. Prabu-Jeyabalan M, et al. Among authors: nalivaika ea. J Virol. 2004 Nov;78(22):12446-54. doi: 10.1128/JVI.78.22.12446-12454.2004. J Virol. 2004. PMID: 15507631 Free PMC article.

8

Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.

Prabu-Jeyabalan M, Nalivaika EA, Romano K, Schiffer CA. Prabu-Jeyabalan M, et al. Among authors: nalivaika ea. J Virol. 2006 Apr;80(7):3607-16. doi: 10.1128/JVI.80.7.3607-3616.2006. J Virol. 2006. PMID: 16537628 Free PMC article.

9

Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.

Prabu-Jeyabalan M, King NM, Nalivaika EA, Heilek-Snyder G, Cammack N, Schiffer CA. Prabu-Jeyabalan M, et al. Among authors: nalivaika ea. Antimicrob Agents Chemother. 2006 Apr;50(4):1518-21. doi: 10.1128/AAC.50.4.1518-1521.2006. Antimicrob Agents Chemother. 2006. PMID: 16569872 Free PMC article.

10

Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.

Altman MD, Nalivaika EA, Prabu-Jeyabalan M, Schiffer CA, Tidor B. Altman MD, et al. Among authors: nalivaika ea. Proteins. 2008 Feb 15;70(3):678-94. doi: 10.1002/prot.21514. Proteins. 2008. PMID: 17729291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters